<ul><li>Patient advocate startup Solace is set to be valued at over $300 million in new funding round from Menlo Ventures.</li><li>Solace is raising a Series B funding round led by Menlo Ventures to simplify tasks like scheduling and payments in healthcare.</li><li>The new round values Solace at more than $300 million, with a target raise of around $40 million.</li><li>Solace connects Medicare patients with healthcare advocates and provides virtual support for over 100 conditions.</li></ul>

Patient advocate startup Solace is set to be valued at over $300 million in new funding round from Menlo Ventures

Discover more